[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 3, Issue 4 (Int J Mol Cell Med 2014) ::
Int J Mol Cell Med 2014, 3(4): 207-215 Back to browse issues page
Hepatitis C Virus and Vaccine Development
Malihe Naderi 1, Naghmeh Gholipour2, Mohammad Reza Zolfaghari3, Binabaj Maryam Moradi4, Ahmad Yegane Moghadam5, Motalleb Gholamreza6
1- Department of Microbiology, Qom branch, Islamic Azad University, Qom, Iran. , rezamotalleb@gmail.com
2- National Institute of Genetic Engineering and Biotechnology, Department of Molecular Genetics, Tehran, Iran.
3- Department of Microbiology, Qom branch, Islamic Azad University, Qom, Iran.
4- Department of Clinical Biochemistry, Faculty of Medicine, Golestan University of Medical Sciences, Golestan, Iran.
5- Kashan University of Medical Sciences, Department of Otolaryngology, Kashan, Iran.
6- Faculty of Science, Department of Biology, University of Zabol, Zabol, Iran.
Abstract:   (6469 Views)
The prevalence of Hepatitis C virus (HCV) is approximately 3% around the world. This virus causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The effectiveness of interferon-α and ribavirin therapy is about 50% and is associated with significant toxicity and cost. Hence, generating new vaccines or drugs is an obligation. However, there is no vaccine available for clinical use. DNA vaccines have some advantages such as producing feasibility and generating intensive cellular and humoral immune responses. Activation and improvement of natural immune defense mechanisms is a necessity for the development of an effective HCV vaccine. This article discusses the current status of therapies for hepatitis C, the promising new therapies and the experimental strategies to develop an HCV vaccine.
Keywords: HCV, DNA vaccine, IFN- α, cellular immune response
Full-Text [PDF 183 kb]   (2099 Downloads)    
Type of Study: Original Article | Subject: Infectious disease (Molecular and Cellular aspects)
Received: 2014/05/23 | Accepted: 2014/08/2 | Published: 2014/09/10
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Naderi M, Gholipour N, Zolfaghari M R, Maryam Moradi B, Moghadam A Y, Gholamreza M. Hepatitis C Virus and Vaccine Development. Int J Mol Cell Med. 2014; 3 (4) :207-215
URL: http://ijmcmed.org/article-1-173-en.html


Volume 3, Issue 4 (Int J Mol Cell Med 2014) Back to browse issues page
International Journal of Molecular and Cellular Medicine (IJMCM) International Journal of Molecular and Cellular Medicine (IJMCM)
Persian site map - English site map - Created in 0.05 seconds with 32 queries by YEKTAWEB 4030